Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Pyrolyx (PLX)

Pyrolyx AG
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:PLX
DateTimeSourceHeadlineSymbolCompany
15/11/201313:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest EliminationsAMEX:PLXProtalix BioTherapeutics Inc.
15/11/201313:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-AMEX:PLXProtalix BioTherapeutics Inc.
15/11/201313:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-AMEX:PLXProtalix BioTherapeutics Inc.
15/11/201313:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest SalesAMEX:PLXProtalix BioTherapeutics Inc.
15/11/201313:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest PurchasesAMEX:PLXProtalix BioTherapeutics Inc.
15/11/201313:12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-AMEX:PLXProtalix BioTherapeutics Inc.
05/02/201323:43Dow Jones NewsU.S. HOT STOCKS: Zynga, Take-Two, Shutterfly Active in Late TradingAMEX:PLXProtalix BioTherapeutics Inc.
05/02/201319:21Dow Jones NewsU.S. HOT STOCKS: Yum Brands, McGraw-Hill, Virgin Media, OpexaAMEX:PLXProtalix BioTherapeutics Inc.
05/02/201317:40Dow Jones NewsProtalix Confirms It's Considering Options; Shares SurgeAMEX:PLXProtalix BioTherapeutics Inc.
11/06/201213:29Dow Jones NewsProtalix Gets $25 Million Milestone Payment For Rare-Disease DrugAMEX:PLXProtalix BioTherapeutics Inc.
01/05/201223:05Dow Jones NewsUPDATE: FDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseAMEX:PLXProtalix BioTherapeutics Inc.
01/05/201222:37Dow Jones NewsCORRECT: FDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseAMEX:PLXProtalix BioTherapeutics Inc.
01/05/201222:07Dow Jones NewsFDA Approves Protalix, Pfizer Drug To Treat Gaucher DiseaseAMEX:PLXProtalix BioTherapeutics Inc.
15/10/200916:50Dow Jones NewsUPDATE: Protalix Gaucher's Treatment Passes Late-Stage TrialAMEX:PLXProtalix BioTherapeutics Inc.
15/10/200911:56Dow Jones NewsProtalix Gaucher's Treatment Passes Late-Stage TrialAMEX:PLXProtalix BioTherapeutics Inc.
31/08/200919:39Dow Jones NewsGenzyme Top Seller Faces Competition Amid Supply IssuesAMEX:PLXProtalix BioTherapeutics Inc.
25/08/200914:06Dow Jones NewsFDA Gives Fast-Track Status To Protalix Drug For Gaucher'sAMEX:PLXProtalix BioTherapeutics Inc.
17/08/200913:35Dow Jones NewsFDA OKs Protalix's Treatment Protocol Drug For Gaucher DiseaseAMEX:PLXProtalix BioTherapeutics Inc.
03/08/200916:54Dow Jones NewsIcagen Rallies, Genzyme Slides On FDA UpdatesAMEX:PLXProtalix BioTherapeutics Inc.
03/08/200908:05Dow Jones NewsShire Says FDA Permits Vela Use; Reports Phase III SuccessAMEX:PLXProtalix BioTherapeutics Inc.
16/07/200910:12Dow Jones NewsUPDATE: Shire Gets Fast-Track Approval For Gaucher-Treating DrugAMEX:PLXProtalix BioTherapeutics Inc.
16/07/200908:25Dow Jones NewsShire Gets Fast-Track Approval For Gaucher-Treating DrugAMEX:PLXProtalix BioTherapeutics Inc.
07/07/200910:11Dow Jones NewsUPDATE:Shire Seeks FDA OK To Provide Vela Amid Drug ShortageAMEX:PLXProtalix BioTherapeutics Inc.
 Showing the most relevant articles for your search:ASX:PLX